The independent laboratory company has entered an agreement to acquire BioReference Health's oncology diagnostic services.
The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw. Labcorp Plasma Complete detects ...
"Labcorp Plasma Complete delivers powerful and comprehensive genomic insights and helps guide targeted treatment decisions even when tissue-based testing is not feasible," said Shakti Ramkissoon ...
Labcorp is in talks with health insurers to see if the test could be covered, Caveney said, adding that it carries a list price of about $240. The test works by measuring four biomarkers ...
Labcorp has entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO ...
The deal is part of BioReference's ongoing effort to streamline its business to achieve profitability and follows the sale last year of clinical laboratory assets to Labcorp.
The liquid biopsy test enables oncologists to perform comprehensive genomic profiling to inform personalized treatment decisions – all from a simple blood draw. "Labcorp Plasma Complete delivers ...